Research and Innovation Golden Jubilee Foundation

Angela Harkness Director of Global Development and Strategic Partnerships Dr Catherine Sinclair Research Manager

NHS Golden Jubilee Foundation Golden Jubilee National Hospital Golden Jubilee Research Institute Golden Jubilee Conference Hotel Golden Jubilee Innovation Centre 3

Scotland’s 2020 vision for Health “To increase investment in innovation which drives quality of care reduce cost provide growth in the economy” Scottish Government

Golden Jubilee’s Vision Leading Quality, Research and Innovation

GJF’s Quality Framework Mortality Complaints Compassion & Caring Incidents & Risk Infection Control Nutrition, Falls, Dementia Satisfaction & Values Involvement in Care Cancellations Values Quality Performance Medical Appraisal Surveys/opinions % Sickness Turnover Leadership Prescribing Financial Capital Wait Times Productivity Diagnostics (Ca) Hotel Occupancy Expansion Plans

GJF’s Quality Framework

GJF’s Quality Framework

Innovation through research The Medical Device alpha Test (MDαT®)

Why MDαT®? 25% research portfolio - device projects Expertise of device related research projects Gap in the market Targeted towards SME’s

MDαT® - our principles Inspired by ‘ideas factory’ concept Panel review of device Expert advisors Non-Disclosure Agreement signed IP belongs to the presenting organisation Outcome reported Continued partnership Introduction though SLA, HIP , word on moth etc Triage – CS, RH and exec team

Case study - Braidlock Introduction - Scottish Lifesciences Association Device - Affixes lines such as IV sets, infusion pumps, Robinson drains, etc. MDαT® event held Outcome Evaluation at the Golden Jubilee

Case study - Synchrophi Introduction - Scottish Lifesciences Association Device - KEWS300, a CE-marked software suite - captures, stores and presents patient vital signs; calculates MEWS scores MDαT® event held Outcome Evaluation – Ward 3 West (cardiothoracic surgery) Partnership and roll out to all wards Option -‘Once for Scotland’ The Modified Early Warning Score (MEWS) is a simple, physiological score that may allow improvement in the quality and safety of management provided to surgical ward patients. The primary purpose is to prevent delay in intervention or transfer of critically ill patients Partnership – visit to hospitals in Galway where device was in use; further development of system to integrate with patient care e-systems; training staff of evaluation ward Evaluation – Real time patient observations; improvement in calculation of EWS – 100% error free; accurate time for repeat observations Ongoing – GJ is a reference site for the device; roll-out on a cost only basis

MDαT® – what next? Golden Jubilee coordinated Share as a Once for Scotland Create a Scotland wide panel review of Medical Devices

Scotland’s passion for innovation

The future - MDαT®

Building Collaboration Route to market Product enhancement - guidance Support delivery Strategic Partnerships Income generation via % return on sales Developing a ‘Once for Scotland’ approach

Building on experience Robust Management and Governance Custodians of SBRI Investment Supporting DHI’s Strategic Partnerships - AF Project Existing commercial relationships - SME’s National and International Links Supporting Economic Growth and Investment Securing return on investment

The Innovation Fund Commercial Partnerships Public Facing Fundraising Match Innovation with Sponsorship/Investments Public Facing Fundraising V Code Innovation, Free Wills etc, Public Fundraising Events Charitable Organisations Promoting Charitable Status. Identifying Projects for Funding European & Worldwide Quality Framework, EPR, ERAS, Gold Care, Research Opportunities Promoting Scotland’s Healthcare worldwide – promote quality, explore consultancy and generate income Alumni & Philanthropic Identify Ambassadors to help link Innovation and Major Donors (e.g. Golden Jubilee Lectures)